•  
  •  
  •  
  •  

2025-10-08 01:57:36

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain

Keywords Selected:  SaregamaIndia

Research

  • Company Update - Saregama India - ICICI Direct
  • Company Update - Saregama India - ICICI Direct

Stock Report

  • Saregama India Ltd consolidated Q4FY25 PAT slips QoQ to Rs. 60.13 crores
  • Saregama India Ltd consolidated Q2FY25 PAT up QoQ at Rs. 44.90 crores
  • SAREGAMA India Ltd Q1 FY2025 consolidated net profit lower at Rs. 36.92 crores
  • Saregama India Ltd posts consolidated PAT of Rs. 48.10 crores in Q2 FY24
  • Saregama India Ltd Q4FY23 consolidated PAT at Rs. 49.28 crores
  • Saregama India Ltd declares interim dividend of Rs. 3
  • Saregama India Ltd reports Rs. 52.52 crores consolidated profit in Q3FY23
  • Saregama India Ltd consolidated Q2 net profit climbs to Rs. 46.07 crores in FY2023
  • Saregama partners with Bollywood music maven Arijit Singh
  • Saregama India Ltd posts consolidated Q1FY23 net profit of Rs. 41.41 crores
  • CARE updates on ratings of Saregama India Ltd
  • Saregama India reports Rs. 48.21 crores consolidated PAT in Q4 FY 2021-22
  • Saregama India Ltd fixes Apr 27, 2022 as record date for stock split
  • Saregama digitises another 10,000 retro songs - Catalogue grows to 1,42,000
  • Saregama India Limited board approves stock split
  • Saregama India Ltd board to consider stock split
  • Saregama acquires Telugu Music Catalogue
  • Saregama India Ltd declares interim dividend of Rs. 30
  • Saregama India Q3FY22 consolidated PAT soars to Rs. 43.40 crores
  • Saregama India Ltd Q2FY22 consolidated PAT rises to Rs. 33.80 crores

Latest Post

  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024